Sunday, 19 January 2025
BREAKING

Health

Eli Lilly’s Zepbound drug likely to dominate global obesity market: Report
OBESITY

Eli Lilly’s Zepbound drug likely to dominate global obesity market: Report

NEW DELHI: Eli Lilly’s Zepbound drug holds potential to dominate the global obesity market due to its superior efficacy and strategic market expansion, a report showed on Tuesday.

Regular eye check-ups in 40s key to preventing vision loss from glaucoma
VISION LOSS

Regular eye check-ups in 40s key to preventing vision loss from glaucoma

NEW DELHI: Adults in their 40s must undergo regular eye check-ups to prevent vision loss from glaucoma -- a chronic eye disease that can lead to vision loss and blindness, said an ophthalmologist at All India Institute of Medical Sciences (AIIMS), New Delhi.

Temporary hospital in Maha Kumbh Mela area sees first birth of baby
THE TEMPORARY HOSPITAL

Temporary hospital in Maha Kumbh Mela area sees first birth of baby

NEW DELHI: A significant milestone was achieved at the temporary hospital in the Maha Kumbh Mela area. Doctors successfully conducted their first delivery of a baby boy, bringing joy to everyone there.

Study shows exercise key to managing chronic liver disease
A CRONERSTONE IN MANAGING

Study shows exercise key to managing chronic liver disease

NEW DELHI: Exercise is a cornerstone in managing metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study led by an Indian-origin researcher.

WHO Chief calls for release of UN staff following negotiation with Houthis
NEGOTIATION

WHO Chief calls for release of UN staff following negotiation with Houthis

SANAA: The negotiation over the release of 13 UN staff arrested by the Houthi group in Yemeni capital Sanaa has concluded, Director General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus said in a statement.

Targeted therapies, diagnostics remain concern for severe asthma: Report
TARGETED THERAPIES

Targeted therapies, diagnostics remain concern for severe asthma: Report

NEW DELHI: There is an urgent need for improved diagnostic tools and targeted therapies to address the gap in care for patients with severe asthma, specifically for those with T-helper cell type 2 (T2)-low asthma, a subtype lacking typical inflammatory biomarkers, according to a report on Friday.

CSIR leads research for breast cancer, sickle cell anaemia, Parkinson's in 2024: Centre
BREAST CANCER

CSIR leads research for breast cancer, sickle cell anaemia, Parkinson's in 2024: Centre

NEW DELHI: The Council of Scientific and Industrial Research (CSIR) has made significant scientific and research gains in 2024, especially for breast cancer, sickle cell anaemia, and Parkinson's disease in the year 2024, said the Ministry of Science and Technology on Friday.

IMA’s new certification for hospitals to promote best practices in antimicrobial usage
ANTIMICROBIAL

IMA’s new certification for hospitals to promote best practices in antimicrobial usage

NEW DELHI: In a bid to combat rising antimicrobial resistance (AMR), the Indian Medical Association (IMA) has launched the first of its kind globally “IMA AMR Smart Hospital” certification initiative that seeks to promote accountability and best practices in antimicrobial usage.

S. Korea's childbirths rise by highest rate in 14 years in October
THE FASTEST RATE

S. Korea's childbirths rise by highest rate in 14 years in October

SEOUL: The number of babies born in South Korea increased by the fastest rate in 14 years in October, data showed on Thursday, as the country is struggling to address the grim demographic changes posed by its ultra-low birth rate and rapid ageing.

India’s Jaduguda Mines discovery extends uranium resources by over 50 years: Govt
THE EXISTING AREA

India’s Jaduguda Mines discovery extends uranium resources by over 50 years: Govt

NEW DELHI: A significant new deposit discovery has been made in and around the existing area of India's Jaduguda Mines which will increase the life of an otherwise depleting mine by more than 50 years, according to the year-end review released by the Department of Atomic Energy on Tuesday.

X